Pfizer's Biotech Sweep
More than satisfied with its genomics deal with Incyte Pharmaceuticals, Pfizer reached out to four new biotech partners to accelerate its understanding of which expressed sequence tags (ESTs), or individual gene sequences, point to promising therapeutics.
You may also be interested in...
Effective medical device regulation supports both safety and innovation needs. This article assesses how well the US FDA and the Australian TGA achieve this balance.
GSK achieved a first-in-class market oncology launch in 2020, but will have to increase that hit rate in order to fulfil its blockbuster ambitions.